Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completed

Clotting Parameters After Medical Abortion

NCT04824118
completednot_applicable

Patient Blood Management for Massive Obstetric Hemorrhage

NCT03784794
completed

Major Liver Resection: Early Clotting Disorders and Functional Impairment.

NCT02813538
unknownnot_applicable

Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant

NCT02239991

Clinical Trials (4)

Showing 4 of 4 trials
NCT04824118

Clotting Parameters After Medical Abortion

Completed
NCT03784794Not Applicable

Patient Blood Management for Massive Obstetric Hemorrhage

Completed
NCT02813538

Major Liver Resection: Early Clotting Disorders and Functional Impairment.

Completed
NCT02239991Not Applicable

Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4